Last reviewed · How we verify
Chronic hepatitis C
Approved treatments
- Sovaldi · Genuine Research Center, Egypt
- Intron A · Merck & Co.
- BECLABUVIR · Bristol-Myers Squibb
- Victrelis · Merck & Co.
- Zepatier · Merck & Co.
Zepatier blocks the NS3/4A protease enzyme, preventing the hepatitis C virus from replicating. - Daklinza · Genuine Research Center, Egypt
- Peginterferon · Ziv Hospital
- Pegasys · Zealand University Hospital
- Norvir · AbbVie
Norvir works by blocking the cytochrome P450 3A enzyme, which helps increase the levels of other medications in the body. - Zepatier · Merck & Co.
Zepatier works by blocking the NS5A protein of the hepatitis C virus, preventing it from replicating. - Daklinza · Bristol-Myers Squibb
- Mavyret · AbbVie
Mavyret works by blocking the NS3/4A protease enzyme, preventing the hepatitis C virus from replicating. - Sunvepra
- Viekira Pak (Copackaged) · AbbVie
- Norvir · Saint Michael's Medical Center
- Ribavarin · Charles University, Czech Republic
- Pegasys · Hoffman-La Roche
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Chronic hepatitis C patent landscape — cliff calendar, originator estates, attackable patents
- Chronic hepatitis C treatment landscape brief
- Chronic hepatitis C treatment updates RSS
Frequently asked questions about Chronic hepatitis C
What drugs treat Chronic hepatitis C?
Tracked treatments include Sovaldi, Intron A, BECLABUVIR, Victrelis, Zepatier, Daklinza, Peginterferon, Pegasys.
What is the treatment for Chronic hepatitis C?
Standard treatment for Chronic hepatitis C includes Sovaldi, Intron A, BECLABUVIR, Victrelis, Zepatier. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Chronic hepatitis C patent cliff · Chronic hepatitis C CI report
- Treatment: Sovaldi · Genuine Research Center, Egypt
- Treatment: Intron A · Merck & Co.
- Treatment: BECLABUVIR · Bristol-Myers Squibb
- Treatment: Victrelis · Merck & Co.
- Treatment: Zepatier · Merck & Co.
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing